BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khan MY, Ponde CK, Kumar V, Gaurav K. Fondaparinux: A cornerstone drug in acute coronary syndromes. World J Cardiol 2022; 14(1): 40-53 [PMID: 35126871 DOI: 10.4330/wjc.v14.i1.40]
URL: https://www.wjgnet.com/1949-8462/full/v14/i1/40.htm
Number Citing Articles
1
Saumitra Ray, Bharat Shivdasani, Jagdish Chander Mohan, V. T. Shah, Jagdish Hiremath, Rajiv Karnik, Bhupen Desai, Hemant Madan, Rajeev Garg, Johann Christopher. Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from IndiaCardiology and Therapy 2023; 12(2): 261 doi: 10.1007/s40119-023-00312-x
2
Monica Singh, Baani Singh, Kirti Sharma, Nitin Kumar, Sarabjit Mastana, Puneetpal Singh. A Molecular Troika of Angiogenesis, Coagulopathy and Endothelial Dysfunction in the Pathology of Avascular Necrosis of Femoral Head: A Comprehensive ReviewCells 2023; 12(18): 2278 doi: 10.3390/cells12182278
3
Kong-Nan Zhao, Paul Masci, Goce Dimeski, Lambro Johnson, Michael Grant, John de Jersey, Martin Lavin. Potential Application of Recombinant Snake Prothrombin Activator Ecarin in Blood DiagnosticsBiomolecules 2022; 12(11): 1704 doi: 10.3390/biom12111704